AIP
CHE icon

Arrowpoint Investment Partners’s Chemed CHE Stock Holding History

Arrowpoint Investment Partners’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96M Buy
+6,365
New +$2.68M 0.65% 31

Other funds holding CHE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Arrowpoint Investment Partners's CHE Position: Q2 2026 in Review

Arrowpoint Investment Partners opened a new position in Chemed (CHE) in Q2 2026: 6,365 shares worth $2.96M. The stake represents 0.65% of the portfolio and ranks #31 among its holdings.

530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Arrowpoint Investment Partners held 6,365 shares of Chemed worth $2.96M as of Q2 2026.
  • Chemed was a new Arrowpoint Investment Partners position in Q2 2026.
  • Chemed made up 0.65% of Arrowpoint Investment Partners's portfolio in Q2 2026, its #31 holding.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Arrowpoint Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.